A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, EUROPEAN MULTICENTRE TRIAL OF TWO NEW BUDESONIDE FORMULATIONS FOR TREATMENT OF ACTIVE EOSINOPHILIC ESOPHAGITIS

Petr Hruz  ¹     Stephan Miehlke  ²     Ulrike von Arnim  ³     Ahmed Madisch  ⁴     Michael Vieth  ⁵     Christiane Fibbe  ⁶     Henning Wittenburg  ⁷     Hans-Dieter Allescher  ⁸     Max Reinshagen     Stefan Schubert     Jan Tack     Michaela Müller     Alexander J. Eckardt     Patrick Krummenerl     Joris Arts     Karin Dilger     Roland Greinwald     Alex Straumann    
¹ University Hospital Basel, Basel, Switzerland
² Center For Digestive Diseases Eppendorf, Hamburg, Germany
³ Otto V. Guericke University, Magdeburg, Germany
⁴ Klinikum Siloah, Hannover, Germany
⁵ Klinikum Bayreuth, Bayreuth, Germany
⁶ Israelitisches Krankenhaus, Hamburg, Germany
⁷ University Hospital Of Leipzig, Leipzig, Germany
⁸ Klinikum

Session
Eosinophilic oesophagitis and other immune mediated upper GI diseases

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)